Latest news with #ShardaCropchem
Business Standard
5 days ago
- Business
- Business Standard
Sharda Cropchem consolidated net profit rises 423.96% in the June 2025 quarter
Sales rise 25.44% to Rs 984.81 croreNet profit of Sharda Cropchem rose 423.96% to Rs 142.78 crore in the quarter ended June 2025 as against Rs 27.25 crore during the previous quarter ended June 2024. Sales rose 25.44% to Rs 984.81 crore in the quarter ended June 2025 as against Rs 785.11 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% 25 OPM %21.869.81 -PBDT247.2295.57 159 PBT169.1430.79 449 NP142.7827.25 424 Powered by Capital Market - Live News
Business Upturn
5 days ago
- Business
- Business Upturn
Why are Sharda Cropchem shares up over 6% today? Explained
By Aditya Bhagchandani Published on July 25, 2025, 13:19 IST Shares of Sharda Cropchem rose sharply by 6.06% to Rs 963.85 in Wednesday's trade after the company reported strong financial results for the quarter ended June 30, 2025. The stock gained Rs 55.10 from its previous close of Rs 908.75 and touched an intraday high of Rs 969.70. Sharda Cropchem reported its #Q1Results with a significant rise in net profit to Rs 143 crore, up from Rs 27 crore in the same quarter last year. Revenue also rose 26% year-on-year to Rs 958 crore from Rs 785 crore. The company recorded a forex gain of Rs 73 crore compared to a loss of Rs 8 crore last year, which contributed to the profit boost. EBITDA increased to Rs 216 crore from Rs 77 crore YoY, and the EBITDA margin improved to 21.9% from 9.8%. The strong performance led to renewed investor interest, pushing the company's market capitalization to Rs 8,702 crore, with the stock trading near its 52-week high of Rs 969.70. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
5 days ago
- Business
- Business Upturn
Sharda Cropchem Q1 results: Revenue up 26% YoY to Rs 958 crore, net profit jumps over 424%
Sharda Cropchem reported its Q1 Results, showcasing a sharp turnaround in profitability and healthy growth in revenue. The company posted a net profit of Rs 143 crore for the quarter ended June 30, 2025, a significant jump from Rs 27 crore in the same period last year. Revenue from operations rose 26% year-on-year to Rs 958 crore, compared to Rs 785 crore in Q1 FY25. The strong performance was driven by improved operational efficiencies and favorable foreign exchange movements. The company recorded a forex gain of Rs 73 crore in Q1 FY26, as against a loss of Rs 8 crore in the previous year. EBITDA for the quarter stood at Rs 216 crore, rising sharply from Rs 77 crore YoY, while EBITDA margin improved to 21.9% from 9.8% last year. This substantial margin expansion highlights Sharda Cropchem's operational leverage and prudent cost management amid rising input costs. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
&w=3840&q=100)
Business Standard
15-07-2025
- Business
- Business Standard
Rallis, RCF, Deepak Fertilisers rally up to 9%; what's driving agri stocks?
Share price movement of agri related stocks Shares of agri related companies like Rallis India, Rashtriya Chemicals and Fertilizers (RCF), Deepak Fertilisers & Petrochemicals Corporation, Paradeep Phosphates and Sharda Cropchem rallied up to 9 per cent on the BSE in Tuesday's intra-day trade after Rallis India reported healthy June quarter (Q1FY26) earnings. Rallis India hit a 52-week high of ₹385.60 on the back of heavy volumes. A combined 16.66 million equity shares changed hands at the counter on the NSE and BSE. Shares of Deepak Fertilisers surged 6 per cent to ₹1,658, followed by RCF (5 per cent to ₹159), Paradeep Phosphates (4 per cent at ₹177.80) and Sharda Cropchem (4 per cent at ₹814.50). UPL, PI Industries and Coromandel International were trading higher in the range of 1 per cent to 3 per cent. In comparison, the BSE Sensex was up 0.14 per cent at 82,368 at 10:28 AM. Rallis India Q1 results Rallis India for the April-June 2025 quarter (Q1FY26) reported revenue of ₹957 crore, up 22 per cent year-on-year (YoY), led by volume led growth in both crop care and seeds businesses. Earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 56.3 per cent at ₹150 crore, while margins came at 15.7 per cent, (up by ~300 bps YoY), driven by volume led growth and moderated fixed cost. Profit after tax stood at ₹95 crore in Q1FY26 as compared to ₹48 crore in Q1FY25. The management has attributed strong performance during the quarter to an early onset of monsoon in the domestic market and recovery in volumes in few products. The growth was indeed driven by volumes thus nullifying the lower GPM impact (lowest in the last 9 quarters). The management remains cautiously optimistic about the coming quarters for the domestic market and gradual recovery in the exports market. Agri - Industry overview With a growing consumer base, the agri-inputs sector stands poised to benefit from a shift towards more efficient, sustainable practices. Opportunities remain abound in developing advanced fertilizers, bio-based solutions and precision agriculture technologies that can increase crop yields while reducing environmental impact. The Asia-Pacific (APAC) crop protection market is expected to grow from $15.5 billion in 2024 to $18.8 billion by 2029, contributing 25.2 per cent to the global market's incremental growth during this period. The region's large and growing population is driving agricultural intensification. This increases the need for effective crop protection solutions to improve yields, said Sharda Cropchem said in its FY25 annual report. Meanwhile, according to Elara Capital, agrochemicals companies, domestic-dependent as well as exports-driven, are likely to see healthy volume growth. Domestic branded companies' top-line growth would be driven by robust placement, due to expectations of normal Monsoon driving healthy agrochemicals demand. If the timing and distribution of Monsoon is favorable, the industry is likely to see sharp consumption growth at the farm level. On the exports side, with destocking largely over globally, fresh demand is driving growth in the international business for our coverage universe. 'Tactically, for the quarter, we prefer domestic agrochemical companies, as we believe, domestic agrochemicals demand can see a significant upswing if the timing and distribution of Monsoon is in balance. Fertilizer companies have seen a healthy run-up in the stock price in the range of 10 per cent-35 per cent in the past three months, and have yet to factor in near-term risk, due to rising raw material prices, in our view,' the brokerage firm said in sector quarterly preview.
&w=3840&q=100)
Business Standard
04-07-2025
- Business
- Business Standard
Stock calls, July 4: Natco Pharma, Sharda Cropchem among top stocks to buy
Stocks to buy: Analyst pick Sharda Cropchem, Monarch Networth Capital and one more share to buy; Check full details Kunal Kamble Mumbai Stock recommendations Sharda Cropchem Sharda Cropchem has given a breakout above its resistance level and closed higher, indicating buyer dominance. The rise in volume during the breakout confirms strong buying interest at current levels. The stock is trading above all major Exponential Moving Averages (EMAs), suggesting a firm positive trend. The RSI, after a brief consolidation, has turned upward, supporting the ongoing price action. Additionally, DI+ trading above DI- signals a bullish stance, while the ADX above both DI lines reflects strength in the upmove. The stock can be accumulated at current levels, with a stop-loss at ₹830 and an upside target of ₹998. Sharda Cropchem: ₹886.90 Stop loss: ₹830 Monarch Networth Capital Monarch Networth has given a breakout from its recent trading range, accompanied by a rise in volume, indicating buyer dominance over sellers. The stock has managed to close above all major EMAs, which suggests the trend remains positive. The RSI is moving higher, supporting the ongoing price action. Additionally, DI+ trading above DI- indicates a bullish bias, while the ADX trading above DI− signals strength in the current upmove. The stock can be accumulated in the range of ₹355–₹372, with a stop-loss at ₹337, for an upside target of ₹391–₹450. Monarch Networth Capital: ₹371.95 Stop Loss: ₹337 Target Price: ₹391/₹450 Natco Pharma Natco Pharma has taken support near the ₹890 level, which previously acted as a strong base from where the stock had rallied up to ₹1,639. Once again, buyers have stepped in at this level, pushing the price higher to ₹973, with the stock now closing above the 9, 21, and 50 EMAs on the weekly timeframe-a sign of emerging bullish momentum. The rise in volume confirms buying interest at current levels. The RSI has crossed above the 50 mark, indicating improving momentum. Additionally, on the weekly chart, DI+ has crossed above DI−, further supporting the positive outlook. The stock can be accumulated on dips toward ₹912, with a stop-loss at ₹840, for an upside target of ₹1,140–₹1,200. Natco Pharma: ₹973.60 Stop Loss: ₹840 Target Price: ₹1140/₹1200
